menu
    • menu

    Company profile for Ultragenyx Pharmaceutical

    NEW Drugs in Dev: 22
    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Lupin Manufacturing Solutions – delivering high-quality APIs & end-to-end CDMO services for faster, cost-effective drug development.

    Virtual Booth

    Contact Supplier

    Minakem delivers API, HPAPI, steroids & CDMO services for generics with FDA/GMP certification, regulatory know-how & proven success.

    Virtual Booth

    Contact Supplier

    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-03-23

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Ultragenyx is a biopharmaceutical company committed to bringing to patients novel products for the treatment of rare and ultra-rare diseases, with a focus on serious, debilitating genetic diseases. Founded in 2010, the company has rapidly built a diverse portfolio of approved therapies and product candidates aimed at addressing diseases with high unmet medical need and clear biology, for which there are no approved therapies. ...
    Ultragenyx is a biopharmaceutical company committed to bringing to patients novel products for the treatment of rare and ultra-rare diseases, with a focus on serious, debilitating genetic diseases. Founded in 2010, the company has rapidly built a diverse portfolio of approved therapies and product candidates aimed at addressing diseases with high unmet medical need and clear biology, for which there are no approved therapies. The company is led by a management team experienced in the development and commercialization of rare disease therapeutics.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Ultragenyx PharmaceuticalUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    60 Leveroni Court Novato, CA 94949
    Telephone
    Telephone
    +1-415-483-8800
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.ultragenyx.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    IPhEB Russia

    Not Confirmed

    envelop Contact Supplier

    IPhEB Russia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Rosen Law Firm Urges Ultragenyx Pharma Stockholders
    Rosen Law Firm Urges Ultragenyx Pharma Stockholders

    03 Apr 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-04-03/rare-deadline-rosen-law-firm-urges-ultragenyx-pharmaceutical-inc-nasdaq-rare-stockholders-with

    PHARMIWEB
    03 Apr 2026
    Share Share
    Ultragenyx Resubmits UX111 AAV Gene Therapy BLA For MPS IIIA
    Ultragenyx Resubmits UX111 AAV Gene Therapy BLA For MPS IIIA

    02 Apr 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/04/02/3267337/20739/en/Ultragenyx-Announces-U-S-FDA-Acceptance-of-BLA-Resubmission-for-UX111-AAV-Gene-Therapy-to-Treat-Sanfilippo-Syndrome-Type-A-MPS-IIIA.html

    GLOBENEWSWIRE
    02 Apr 2026
    Share Share
    FDA Clears Ultragenyx's UX016 IND for GNE Myopathy
    FDA Clears Ultragenyx's UX016 IND for GNE Myopathy

    30 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/30/3264623/20739/en/Ultragenyx-Announces-FDA-Clearance-of-Investigational-New-Drug-IND-Application-for-UX016-a-Sialic-Acid-Prodrug-for-the-Treatment-of-GNE-Myopathy.html

    GLOBENEWSWIRE
    30 Mar 2026
    Share Share
    Robbins LLP Urges RARE Securities Investors to Join Fraud Suit
    Robbins LLP Urges RARE Securities Investors to Join Fraud Suit

    25 Mar 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-03-25/rare-investor-alert-ultragenyx-pharmaceutical-inc-stockholders-with-large-losses-should-contact-ro

    PHARMIWEB
    25 Mar 2026
    Share Share
    Ultragenyx Issues Inducement Grant Per Nasdaq LR 5635(C)(4)
    Ultragenyx Issues Inducement Grant Per Nasdaq LR 5635(C)(4)

    20 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/20/3259953/20739/en/Ultragenyx-Reports-Inducement-Grant-Under-Nasdaq-Listing-Rule-5635-c-4.html

    GLOBENEWSWIRE
    20 Mar 2026
    Share Share
    Ultragenyx Gene Therapy Cuts Ammonia in Phase 3 Trial
    Ultragenyx Gene Therapy Cuts Ammonia in Phase 3 Trial

    13 Mar 2026

    // FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/ultragenyx-gene-therapy-lessens-ammonia-levels-ph-3-rare-disease-win

    FIERCE BIOTECH
    13 Mar 2026
    Share Share

    Inspections and registrations

    Upload your audits for free, ask us

    ABOUT THIS PAGE

    Contact Ultragenyx Pharmaceutical and get a quotation

    Ultragenyx Pharmaceutical is a supplier offers 1 products (APIs, Excipients or Intermediates).

    Find a price of Triheptanoin bulk with DMF offered by Ultragenyx Pharmaceutical

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search